Skip to main content

Day: August 30, 2024

PlantX Announces Filing of Interim Financial Statements for the Three Months Ended June 30, 2024

VANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) — PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) (“PlantX” or the “Company”), the digital face of the plant-based community, operating a one-stop shop for plant-based products, announces the filing of its unaudited condensed interim consolidated financial statements, associated management’s discussion, and analysis and related officer certifications for the three months period ended June 30, 2024 (the “Q1 Filing”). The Q1 Filing is available under the Company’s SEDAR profile at www.sedar.com. Highlights For the Three Months ended June 30,2024 The gross revenue for the three months ended June 2024, was $ 1,299,761 (June 2023; $2,794,942). The cost of goods sold for the three months ended June 2024, was $ 473,728 (June 2023; $1,687,302). The net...

Continue reading

Richtech Robotics Announces Pricing of Upsized $21 Million Public Offering

LAS VEGAS, Aug. 29, 2024 (GLOBE NEWSWIRE) — Richtech Robotics Inc. (Nasdaq: RR), (“Richtech Robotics” or the “Company”), a Nevada-based provider of AI-driven service robots, today announced the pricing of an upsized public offering of an aggregate of 15,555,557 shares of its Class B common stock (or Class B common stock equivalents in lieu thereof), warrants to purchase up to 15,555,557 shares of Class B common stock (the “Warrants”), at a combined public offering price of $1.35 per share (or per Class B common stock equivalent in lieu thereof) and accompanying Warrant. The Warrants will have an exercise price of $1.35 per share, will be exercisable immediately upon issuance and will expire on the five year anniversary of the initial issuance date. The closing of the offering is expected to occur on or about September 3, 2024,...

Continue reading

Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering

SAN RAFAEL, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced the pricing of an underwritten public offering of 6,000,000 total units and pre-funded units for gross proceeds of approximately $6.0 million prior to deducting underwriting discounts and commissions and offering expenses. The offering is comprised of 3,100,000 units, priced at a public offering price of $1.00 per unit, with each unit consisting of one share of common stock, one warrant to purchase one share of common stock at an exercise price of $1.00 per share that expires on the fifth anniversary of the date of issuance (a “Series A Warrant”) and one warrant to purchase one share of common stock at an exercise...

Continue reading

Airship AI Announces Pricing of $8.0 Million Public Offering Priced At-Market According to Nasdaq Rules

REDMOND, Wash., Aug. 29, 2024 (GLOBE NEWSWIRE) — Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), a leader in AI-driven video, sensor, and data management surveillance solutions, today announced the pricing of a public offering priced at-market according to Nasdaq rules of 2,882,883 shares of its common stock and warrants to purchase up to an aggregate of 2,882,883 shares of its common stock at a combined public offering price of $2.775 per share and associated common warrant. Each share of common stock is being sold together with one warrant to purchase one share of common stock. The warrants will have an exercise price of $2.65 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance. The closing of the offering is expected to occur on or about September...

Continue reading

Western Investment Company Reports Financial Results for the Second Quarter of 2024

CALGARY, Alberta, Aug. 29, 2024 (GLOBE NEWSWIRE) — The Western Investment Company of Canada Limited (TSXV: WI) (“Western” or the “Corporation”) today reported its financial and operating results for the three and six months ended June 30, 2024. Western also announced that it will delay its Annual General and Special Meeting of shareholders (the “Meeting”) to amend the terms of the transaction with Tevir Capital Corp. (“Tevir“), and other affiliates of Paul Rivett, that was previously announced on March 22, 2024 (the “Transaction”). Transaction and Annual General and Special Meeting UpdateWestern is in the process of amending the Transaction terms and, once finalized, the new terms will be announced in a subsequent news release. As such, Western will delay its Shareholder Meeting which was to take place on August 30th,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.